SCHEMBL22079013

SCHEMBL22079013

c1ccc(-c2ccc(-c3ccccc3-c3ccc(N(c4ccc(-c5cccc(-c6ccccc6)c5)cc4)c4ccc(-c5cccc(-c6ccccc6)c5)cc4)cc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
APAF1 O14727 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.42
XBP1 P17861 1/20 0.42
PTBP1 P26599 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
GALK1 P51570 1/20 0.42
BLM P54132 1/20 0.42
SMAD3 P84022 1/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ESR1 P03372 1/20 0.41
MGLL Q99685 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079919 1.00 MEN1 (0.42) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079056 1.00 MEN1 (0.42) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079050 1.00 MEN1 (0.42) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079010 1.00 MEN1 (0.42) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079576 1.00 MEN1 (0.42) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079035 0.98 MEN1 (0.41) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079679 0.98 MEN1 (0.41) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079657 0.98 MEN1 (0.41) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079958 0.98 MEN1 (0.41) MEN1KMT2AMAPTL3MBTL1APAF1
SCHEMBL22079983 0.98 MEN1 (0.41) MEN1KMT2AMAPTL3MBTL1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200185612-A1 COMPOUND, LIGHT-EMITTING ELEMENT CONTAINING THE SAME, DISPLAY DEVICE, AND LIGHTING DEVICE TORAY INDUSTRIES, INC. (JP) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200185612-A1 COMPOUND, LIGHT-EMITTING ELEMENT CONTAINING THE SAME, DISPLAY DEVICE, AND LIGHTING DEVICE NR2E3, PER2, CRY2 MEN1 2040/4885KMT2A 1049/4885MAPT 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.